Log In
BCIQ
Print this Print this
 

Motrem

  Manage Alerts
Collapse Summary General Information
Company Inotrem S.A.
DescriptionTriggering receptor expressed on myeloid cells 1 (TREM1) pathway modulator
Molecular Target Triggering receptor expressed on myeloid cells 1 (TREM1)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase I
Standard IndicationSepsis
Indication DetailsTreat septic shock
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today